Goldman Sachs Group Inc Sangamo Therapeutics, Inc Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,606,909 shares of SGMO stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,606,909
Previous 68,481 2246.5%
Holding current value
$1.35 Million
Previous $58,000 2725.86%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.78 - $2.87 $1.2 Million - $4.42 Million
1,538,428 Added 2246.5%
1,606,909 $1.64 Million
Q3 2024

Nov 14, 2024
SELL
$0.32 - $1.1 $404,791 - $1.39 Million
-1,264,973 Reduced 94.86%
68,481 $58,000
Q2 2024

Aug 13, 2024
BUY
$0.36 - $0.65 $252,297 - $455,536
700,826 Added 110.78%
1,333,454 $480,000
Q1 2024

May 15, 2024
BUY
$0.42 - $1.38 $156,636 - $514,661
372,943 Added 143.61%
632,628 $423,000
Q4 2023

Feb 13, 2024
SELL
$0.3 - $0.63 $409,571 - $860,099
-1,365,238 Reduced 84.02%
259,685 $140,000
Q3 2023

May 14, 2024
BUY
$0.58 - $1.47 $791,838 - $2.01 Million
1,365,238 Added 525.73%
1,624,923 $974,000
Q3 2023

Nov 14, 2023
BUY
$0.58 - $1.47 $292,726 - $741,910
504,701 Added 45.05%
1,624,923 $974,000
Q2 2023

May 14, 2024
BUY
$1.11 - $1.74 $51,154 - $80,187
46,085 Added 4.29%
1,120,222 $1.46 Million
Q2 2023

Aug 14, 2023
BUY
$1.11 - $1.74 $51,154 - $80,187
46,085 Added 4.29%
1,120,222 $1.46 Million
Q1 2023

May 14, 2024
SELL
$1.66 - $3.67 $287,246 - $635,056
-173,040 Reduced 13.87%
1,074,137 $1.89 Million
Q1 2023

May 11, 2023
SELL
$1.66 - $3.67 $287,246 - $635,056
-173,040 Reduced 13.87%
1,074,137 $1.89 Million
Q4 2022

May 14, 2024
BUY
$2.77 - $5.07 $147,062 - $269,171
53,091 Added 4.45%
1,247,177 $3.92 Million
Q4 2022

Feb 13, 2023
BUY
$2.77 - $5.07 $147,062 - $269,171
53,091 Added 4.45%
1,247,177 $3.92 Million
Q3 2022

May 14, 2024
SELL
$4.27 - $6.39 $1.09 Million - $1.63 Million
-254,573 Reduced 17.57%
1,194,086 $5.85 Million
Q3 2022

Nov 10, 2022
SELL
$4.27 - $6.39 $1.09 Million - $1.63 Million
-254,573 Reduced 17.57%
1,194,086 $5.85 Million
Q2 2022

May 14, 2024
BUY
$3.28 - $6.21 $3.9 Million - $7.38 Million
1,188,974 Added 457.85%
1,448,659 $6 Million
Q2 2022

Aug 15, 2022
BUY
$3.28 - $6.21 $934,052 - $1.77 Million
284,772 Added 24.47%
1,448,659 $6 Million
Q1 2022

May 16, 2022
SELL
$5.23 - $7.82 $277,237 - $414,530
-53,009 Reduced 4.36%
1,163,887 $6.76 Million
Q4 2021

Feb 14, 2022
SELL
$7.29 - $10.97 $3.12 Million - $4.69 Million
-427,428 Reduced 25.99%
1,216,896 $9.13 Million
Q3 2021

Nov 10, 2021
BUY
$9.01 - $12.01 $14.8 Million - $19.7 Million
1,644,324 New
1,644,324 $14.8 Million

Others Institutions Holding SGMO

# of Institutions
141
Shares Held
60.4M
Call Options Held
1.46M
Put Options Held
1.84M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $132M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email